Case report: Successful treatment of refractory immune thrombocytopenia in chronic lymphocytic leukaemia with venetoclax monotherapy

In chronic lymphocytic leukaemia (CLL), immune dysregulation is common and can manifest as immune thrombocytopenia (ITP). Corticosteroids are the mainstay for front-line management of CLL-associated ITP. Therapy refractoriness represents a clinical challenge and is an indication to commence CLL-dire...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Timothy Woo, Matthew Carter, George Follows, Piers EM. Patten
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2023-10-01
Edice:	Frontiers in Oncology
Témata:	chronic lymphocytic leukaemia immune thrombocytopenia refractory venetoclax monotherapy
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1260003/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!